查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429521

2024 年介入性肿瘤设备全球市场报告

Interventional Oncology Devices Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

介入肿瘤设备的市场规模预计在未来几年将显着成长。预计到 2028 年将以 6.7% 的复合年增长率 (CAGR) 增长至 32.5 亿美元。预测期内的预期成长是由于老年人口增加、对微创手术（MIS）的偏好增加、研发支出增加、医疗保健支出增加、新兴经济体的巨大潜力以及经济成长。这可能是由于等因素。癌症和慢性病的发生率增加。预测期内预期的显着趋势包括重点开发先进的影像引导肿瘤治疗设备、利用人工智慧（AI）创建创新设备以及利用人工智慧（AI）增强肿瘤治疗。和创新的栓塞设备以及对机器人技术的使用的重视。利用技术并与其他公司和研究机构合作，加速产品开发和创新。

由于私人和政府来源的资金的可用性，介入肿瘤设备市场见证了成长。增加对癌症研究的资助，特别是治疗中使用的设备，将有助于早期检测的进步和提高存活率。主要的非政府癌症研究资助者美国癌症协会在 2021 年为 630 个计划津贴384,262,652 美元。一个着名的资金筹措例子是 BioProtect Ltd.，这是一家为前列腺癌患者开发生物可吸收聚合物间隔球囊的以色列公司，该公司获得了来自创业投资人，获得了 1300 万美元。此外，第一个扩增实境引导消融系统 Endosight 的 20% 资金来自私人组织。这些资金筹措倡议将促进创新技术和设备的发展，进而推动介入肿瘤设备市场。

由于癌症的高发生率，介入肿瘤设备市场可望成长。癌症以不受控制的细胞增殖为特征，对用于诊断、治疗和管理的介入性肿瘤设备产生了巨大的需求。例如，麦克米伦癌症支持组织估计，2020 年将有300 万人患有癌症，预计到2025 年将增至350 万人，到2030 年将增至400 万人，到2040 年将增至530 万人。癌症盛行率的上升是介入肿瘤设备市场的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球介入性肿瘤设备市场，依产品细分、实际及预测，2018-2023、2023-2028、2033
  • 栓塞装置
  • 消融装置
  • 支撑装置
  • 全球介入性肿瘤设备市场，按程序、性能和预测细分，2018-2023、2023-2028、2033
  • 肿瘤热消融术
  • 非热肿瘤消融
  • 经导管动脉化疗栓塞术（TACE）
  • 经导管动脉放射栓塞 (TARE) 或选择性体内放射治疗 (SIRT)
  • 经导管动脉栓塞 (TAE) 或品牌栓塞
  • 全球介入性肿瘤器材市场，依癌症类型、表现和预测细分，2018-2023、2023-2028、2033
  • 肝癌
  • 肾癌
  • 肺癌
  • 骨癌
  • 其他癌症类型

第 7 章 区域与国家分析

  • 全球介入性肿瘤设备市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球介入性肿瘤设备市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 介入性肿瘤器材市场竞争形势
  • 介入性肿瘤设备市场公司概况
    • Boston Scientific Corporation
    • Terumo Corporation
    • Siemens Healthineers
    • Sirtex Medical Limited
    • Merit Medical Systems, Inc.

第31章 其他大型创新公司

  • Merck &Co. Inc.
  • CVS Health
  • Henlius
  • Viant Medical
  • AngioDynamics Inc.
  • Pfizer
  • Steris Applied Sterilization Technologies
  • Co, Dr.Reddy's
  • International SOS
  • CapeRay
  • Innovent Biologics
  • Novartis AG
  • Consonance
  • ABLbio
  • Adimmune

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14492

Interventional oncology devices are utilized in the diagnosis and treatment of cancer through minimally invasive techniques and advanced imaging technology.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown strongly in recent years. It will grow from $2.35 billion in 2023 to $2.5 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the historical period can be attributed to factors such as an aging population pool, an increase in cancer prevalence, an uptick in pharmaceutical research and development (R&D) expenditure, increased healthcare expenditure, and growth in the number of healthcare facilities.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.25 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to factors such as the increasing older population, a growing preference towards minimally invasive surgeries (MIS), escalating research and development spending, a rise in healthcare expenditure, high potential in emerging economies, and an increasing prevalence of cancer and chronic diseases. Notable trends expected in the forecast period include a focus on developing advanced image-guided oncology devices, the utilization of artificial intelligence (AI) to create innovative devices, the development of new and innovative embolic devices to enhance oncology procedures, an emphasis on using robotics technology, and collaboration with other companies and research institutes to accelerate product development and innovation.

The interventional oncology devices market has experienced growth driven by the availability of funding from both private and government sources. Increased funding in cancer research, especially for devices used in treatments, contributes to advancements in early detection and improved survival rates. In 2021, the American Cancer Society, a major non-governmental cancer research funder, allocated $384,262,652 in grants to 630 projects. Notable funding examples include BioProtect Ltd., an Israeli company developing bioabsorbable polymer spacer balloons for prostate cancer patients, which received $13 million in Series D equity financing from venture investors. Additionally, Endosight, the first augmented-reality-guided ablative system, secured 20% of its funding from private organizations. These funding initiatives foster the development of innovative technologies and devices, thereby propelling the interventional oncology devices market.

The interventional oncology devices market is poised for growth due to the high prevalence of cancer. Cancer, characterized by uncontrolled cell growth, creates a substantial demand for interventional oncology devices used in diagnosis, treatment, and management. For instance, Macmillan Cancer Support estimated 3 million people with cancer in 2020, projecting an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This heightened prevalence of cancer is a significant driver for the interventional oncology devices market.

Companies in the interventional oncology devices market are increasingly incorporating robotics technology to enhance efficiency. Robotic systems integrate image-based planning and navigation, allowing accurate and efficient installation of instruments to specific body parts. In March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform, showcasing the industry's commitment to technological advancements.

Major players in the interventional oncology devices market are focused on innovation, such as AI-powered digital pathology solutions, to enhance the accuracy of breast cancer diagnosis. Paige AI Inc., a U.S.-based biotechnology company, launched Paige Breast Lymph Node in March 2022, an AI-powered digital pathology solution improving the detection of breast cancer metastases in lymph node tissue. This technology offers AI-driven detection capabilities, a convenient heat map overlay, high sensitivity and specificity, seamless integration into existing workflows, user-friendliness, and robust security measures.

In August 2022, Boston Scientific Corporation acquired Obsidio Inc. for an undisclosed amount, aiming to expand its interventional oncology portfolio and strengthen its position in the growing market. Obsidio Inc., a U.S.-based medical device company, specializes in developing minimally invasive interventional oncology devices for treating liver cancer and other solid tumors.

Major companies operating in the interventional oncology devices market report are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Merit Medical Systems, Inc., Merck & Co. Inc., CVS Health, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, CoDr.Reddys, International SOS, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic PLC, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc., Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

North America was the largest region in the interventional oncology devices market in 2023. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Embolization Devices; Ablation Devices; Support Devices
  • 2) By procedure: Thermal Tumor Ablation; Non-Thermal Tumor Ablation; Transcatheter Arterial Chemoembolization (TACE); Transcatheter Arterial Radioembolization (TARE); Selective Internal Radiation Therapy (SIRT); Transcatheter Arterial Embolization (TAE); Bland Embolization
  • 3) By Cancer Type: Liver Cancer; Kidney Cancer; Lung Cancer; Bone Cancer; Other Cancer Types
  • Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; Merit Medical Systems, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Devices Market Characteristics

3. Interventional Oncology Devices Market Trends And Strategies

4. Interventional Oncology Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Interventional Oncology Devices Market Size and Growth

  • 5.1. Global Interventional Oncology Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Interventional Oncology Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Interventional Oncology Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Interventional Oncology Devices Market Segmentation

  • 6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Embolization Devices
  • Ablation Devices
  • Support Devices
  • 6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE) or Bland Embolization
  • 6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancer Types

7. Interventional Oncology Devices Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Interventional Oncology Devices Market

  • 8.1. Asia-Pacific Interventional Oncology Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Interventional Oncology Devices Market

  • 9.1. China Interventional Oncology Devices Market Overview
  • 9.2. China Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Interventional Oncology Devices Market

  • 10.1. India Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Interventional Oncology Devices Market

  • 11.1. Japan Interventional Oncology Devices Market Overview
  • 11.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Interventional Oncology Devices Market

  • 12.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Interventional Oncology Devices Market

  • 13.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Interventional Oncology Devices Market

  • 14.1. South Korea Interventional Oncology Devices Market Overview
  • 14.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Interventional Oncology Devices Market

  • 15.1. Western Europe Interventional Oncology Devices Market Overview
  • 15.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Interventional Oncology Devices Market

  • 16.1. UK Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Interventional Oncology Devices Market

  • 17.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Interventional Oncology Devices Market

  • 18.1. France Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Interventional Oncology Devices Market

  • 19.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Interventional Oncology Devices Market

  • 20.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Interventional Oncology Devices Market

  • 21.1. Eastern Europe Interventional Oncology Devices Market Overview
  • 21.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Interventional Oncology Devices Market

  • 22.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Interventional Oncology Devices Market

  • 23.1. North America Interventional Oncology Devices Market Overview
  • 23.2. North America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Interventional Oncology Devices Market

  • 24.1. USA Interventional Oncology Devices Market Overview
  • 24.2. USA Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Interventional Oncology Devices Market

  • 25.1. Canada Interventional Oncology Devices Market Overview
  • 25.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Interventional Oncology Devices Market

  • 26.1. South America Interventional Oncology Devices Market Overview
  • 26.2. South America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Interventional Oncology Devices Market

  • 27.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Interventional Oncology Devices Market

  • 28.1. Middle East Interventional Oncology Devices Market Overview
  • 28.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Interventional Oncology Devices Market

  • 29.1. Africa Interventional Oncology Devices Market Overview
  • 29.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Devices Market Competitive Landscape
  • 30.2. Interventional Oncology Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Terumo Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sirtex Medical Limited
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merit Medical Systems, Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Interventional Oncology Devices Market Other Major And Innovative Companies

  • 31.1. Merck & Co. Inc.
  • 31.2. CVS Health
  • 31.3. Henlius
  • 31.4. Viant Medical
  • 31.5. AngioDynamics Inc.
  • 31.6. Pfizer
  • 31.7. Steris Applied Sterilization Technologies
  • 31.8. Co, Dr.Reddy's
  • 31.9. International SOS
  • 31.10. CapeRay
  • 31.11. Innovent Biologics
  • 31.12. Novartis AG
  • 31.13. Consonance
  • 31.14. ABLbio
  • 31.15. Adimmune

32. Global Interventional Oncology Devices Market Competitive Benchmarking

33. Global Interventional Oncology Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

35. Interventional Oncology Devices Market Future Outlook and Potential Analysis

  • 35.1 Interventional Oncology Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer